Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283]. (Q24816432)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283]. |
scientific article |
Statements
1 reference
Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283]. (English)
1 reference
H Friess
1 reference
M W Buchler
1 reference
K K Herfarth
1 reference
R Krempien
1 reference
M W Muenter
1 reference
P E Huber
1 reference
S Nill
1 reference
C Timke
1 reference
B Didinger
1 reference
P Buechler
1 reference
S Heeger
1 reference
A Abdollahi
1 reference
11 October 2005
1 reference
1
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference